Newsroom | 39893 results

ORLANDO, Fla.--(BUSINESS WIRE)--Imaginostics, Inc. today announced that it has received a Letter of Support from Siemens Healthineers in connection with ongoing exploratory discussions regarding potential collaboration in quantitative MRI and imaging biomarkers. As part of these discussions, Imaginostics and Siemens Healthineers intend to continue dialogue concerning potential technical and commercial pathways for Imaginostics’ envisioned ImagiView™ and ImagiSight™ offerings and their potential...

TORRANCE, Calif.--(BUSINESS WIRE)--A new global Alliance between Hamamatsu Photonics K.K and Sakura Finetek Global...

CRYSTAL LAKE, Ill,--(BUSINESS WIRE)--Aptar’s Unidose Powder Nasal Delivery System Used in ENA Respiratory Phase II Clinical Study of Investigational INNA‑051 Nasal Spray...

BOSTON & ALLENTOWN, Pa.--(BUSINESS WIRE)--Ibex Medical Analytics (Ibex), a leader in clinical-grade AI-powered pathology, today announced a strategic collaboration with HNL Lab Medicine, a leading multi-regional medical laboratory in the United States. Through this partnership, HNL Lab Medicine will deploy Ibex’s advanced AI solutions, Ibex Prostate for biopsies and transurethral resection of the prostate (TURP), to further enhance diagnostic accuracy and workflow efficiency. The deployment mar...

PALO ALTO, Calif.--(BUSINESS WIRE)--Siemens Healthineers announced that its Varian TrueBeam radiotherapy systems, which include TrueBeam, TrueBeam STx, VitalBeam, and Edge, have received FDA 510(k) clearance for the use of low-dose radiation therapy (LDRT) in adults with medically refractory osteoarthritis (OA). This clearance expands Varian’s radiotherapy systems beyond cancer care into chronic musculoskeletal conditions, bringing precision radiotherapy to millions of people living with persis...

JASPER, Ind.--(BUSINESS WIRE)--Kimball Electronics, Inc. (Nasdaq: KE) today announced the release of its 2025 Guiding Principles Report, which includes the company’s annual sustainability disclosures. Themed “Building Tomorrow, Together,” the Report outlines progress on environmental, social, and governance (ESG) initiatives and reflects the company’s continued focus on the issues that matter most—where it can make a meaningful and lasting difference for people and the environment, while suppor...

LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced the U.S. Food and Drug Administration (FDA) granted premarket approval (PMA) for the aura6000™ System for the treatment of adult patients with moderate to severe Obstructive Sleep Apnea (OSA). The System utilizes proximal hypoglossal nerve stimulation (p-HGNS), a differentiated neurostimulation modality, to treat OSA in patients with an apnea-hypopnea index (AHI) between 15 and 65...

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced that it will report financial results for the third quarter of fiscal year 2026 before the market open on Thursday, April 2, 2026. The Company’s management will host a conference call at 8:00 am ET the same day to d...

HOUSTON & PANAMA CITY, Panama--(BUSINESS WIRE)--XCath announced successful completion of world’s first telerobotic mechanical thrombectomy for stroke using the XCath Iris Surgical Robotic System....

BOSTON--(BUSINESS WIRE)--Sempresto, Inc., a company developing a next-generation platform for smartphone-integrated rescue medications, today announced that it has been featured in a recent Inc. article by Chloe Capital, highlighting Alerje and its innovative approach to improving access to life-saving treatment for individuals with severe allergies. The article underscores the origins of Alerje’s technology, which, like Sempresto’s, was developed to address real-world challenges faced by patie...